{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:03:20Z","timestamp":1788397400969,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajt.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:55:36Z","timestamp":1728496536000},"page":"259-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum and tissue biomarkers of plasma cell-rich rejection in liver transplant recipients"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-6679","authenticated-orcid":false,"given":"Nivetha","family":"Saravanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-3733","authenticated-orcid":false,"given":"Anthony","family":"Demetris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-6313","authenticated-orcid":false,"given":"Maria Isabel","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2577-9087","authenticated-orcid":false,"given":"Claire","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigar Anjuman","family":"Khurram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-5101","authenticated-orcid":false,"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-6093","authenticated-orcid":false,"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajt.2024.10.006_bib1","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2024.10.006_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5500\/wjt.v12.i3.59","article-title":"Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis","volume":"12","author":"Harputluoglu","year":"2022","journal-title":"World J Transplant"},{"issue":"9100","key":"10.1016\/j.ajt.2024.10.006_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajt.2024.10.006_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cld.1234","article-title":"Alloimmune versus autoimmune hepatitis following liver transplantation","volume":"20","author":"Harrington","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.ajt.2024.10.006_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinbiochem.2012.10.010","article-title":"Biomarker discovery in transplantation--proteomic adventure or mission impossible?","volume":"46","author":"Kienzl-Wagner","year":"2013","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.ajt.2024.10.006_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2249.2001.01682.x","article-title":"Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation","volume":"126","author":"Aguilera","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.ajt.2024.10.006_bib7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/lt.20209","article-title":"Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation","volume":"10","author":"Aguilera","year":"2004","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.ajt.2024.10.006_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Montano-Loza","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.ajt.2024.10.006_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.ajt.2024.10.006_bib10","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/ajt.15053","article-title":"Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy","volume":"18","author":"Chan","year":"2018","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2024.10.006_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jhep.2013.10.037","article-title":"Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation","volume":"60","author":"Ikegami","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.ajt.2024.10.006_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.20404","article-title":"Antibodies against cytokeratin 8\/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation","volume":"11","author":"Inui","year":"2005","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.ajt.2024.10.006_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/tri.13801","article-title":"Incidence of de novo autoimmune hepatitis in children and adolescents with increased autoantibodies after liver transplantation: a meta-analysis","volume":"34","author":"Ma","year":"2021","journal-title":"Transpl Int."},{"issue":"1","key":"10.1016\/j.ajt.2024.10.006_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ajt.2024.10.006_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/lt.24652","article-title":"De novo autoimmune hepatitis after liver transplantation: a focus on glutathione S-transferase theta 1","volume":"23","author":"Ib\u00e1\u00f1ez-Samaniego","year":"2017","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.ajt.2024.10.006_bib16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.22302","article-title":"Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis","volume":"17","author":"Aguilera","year":"2011","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.ajt.2024.10.006_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/lt.26501","article-title":"CAQ Corner: Basic concepts of transplant immunology","volume":"29","author":"Cheung","year":"2023","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.ajt.2024.10.006_bib18","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1111\/ajt.12413","article-title":"\u201cPlasma cell hepatitis\u201d in liver allografts: identification and characterization of an IgG4-rich cohort","volume":"13","author":"Castillo-Rama","year":"2013","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2024.10.006_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2024.10.006_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ajt.2024.10.006_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/lt.21721","article-title":"Risk factors for developing de novo autoimmune hepatitis associated with anti\u2013glutathione S-transferase T1 antibodies after liver transplantation","volume":"15","author":"Salcedo","year":"2009","journal-title":"Liver Transpl"},{"issue":"27","key":"10.1016\/j.ajt.2024.10.006_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4254\/wjh.v9.i27.1115","article-title":"T-cell allorecognition of donor glutathione S-transferase T1 in plasma cell-rich rejection","volume":"9","author":"Mart\u00ednez-Bravo","year":"2017","journal-title":"World J Hepatol"},{"issue":"8","key":"10.1016\/j.ajt.2024.10.006_bib23","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.1900488","article-title":"CD24hiCD38hi and CD24hiCD27+ human regulatory B cells display common and distinct functional characteristics","volume":"203","author":"Hasan","year":"2019","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.ajt.2024.10.006_bib24","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.1502276","article-title":"Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells","volume":"196","author":"Arterbery","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajt.2024.10.006_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01612","article-title":"Inflammasome priming mediated via toll-like receptors 2 and 4, induces Th1-like regulatory T cells in de novo autoimmune hepatitis","volume":"9","author":"Arterbery","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2024.10.006_bib26","article-title":"Differential IgG4-producing plasma cell infiltration in non- and post-transplant plasma cell hepatitis","volume":"35","author":"Horwich","year":"2022","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.ajt.2024.10.006_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ajcp\/aqad004","article-title":"Histologic and clinical outcomes of patients developing post-liver transplant plasma cell-rich rejection","volume":"160","author":"Ozturk","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.ajt.2024.10.006_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","article-title":"A\u00a0review of complement activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ajt.2024.10.006_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.humpath.2017.12.007","article-title":"Global quality assessment of liver allograft C4d staining during acute antibody-mediated rejection in formalin-fixed, paraffin-embedded tissue","volume":"73","author":"Neil","year":"2018","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.ajt.2024.10.006_bib30","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/hep.32591","article-title":"Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis","volume":"76","author":"Harrington","year":"2022","journal-title":"Hepatology"},{"issue":"36","key":"10.1016\/j.ajt.2024.10.006_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030493","article-title":"Plasma cell-rich related acute rejection in kidney transplant: a case report and review of the literature","volume":"101","author":"Tsai","year":"2022","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ajt.2024.10.006_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/01.tp.0000231922.11453.ec","article-title":"Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft","volume":"82","author":"Adrogue","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ajt.2024.10.006_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/TP.0000000000002041","article-title":"Clinical and pathological features of plasma cell-rich acute rejection after kidney transplantation","volume":"102","author":"Hasegawa","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2024.10.006_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/1319-2442.335451","article-title":"Plasma cell rich acute rejection: risk factors, treatment and outcomes","volume":"32","author":"Mendonca","year":"2021","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"9","key":"10.1016\/j.ajt.2024.10.006_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/ctr.12589","article-title":"Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases","volume":"29","author":"Abbas","year":"2015","journal-title":"Clin Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.ajt.2024.10.006_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nep.13273","article-title":"Clinicopathological and immunohistochemical analysis of plasma cell-rich rejection in renal transplantation: involvement of intratubular Th1\/Th2 balance in plasma cell enrichment","volume":"23","author":"Nishimura","year":"2018","journal-title":"Nephrology (Carlton)"},{"issue":"9","key":"10.1016\/j.ajt.2024.10.006_bib37","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00467-022-05872-z","article-title":"Rejection markers in kidney transplantation: do new technologies help children?","volume":"38","author":"Peruzzi","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.ajt.2024.10.006_bib38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/TP.0b013e3181d3f271","article-title":"B\u00a0cells and plasma cells in coronaries of chronically rejected cardiac transplants","volume":"89","author":"Wehner","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2024.10.006_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845867","article-title":"B\u00a0cell immunity in lung transplant rejection\u2014effector mechanisms and therapeutic implications","volume":"13","author":"Ohm","year":"2022","journal-title":"Front Immunol"},{"issue":"Suppl 14","key":"10.1016\/j.ajt.2024.10.006_bib40","doi-asserted-by":"crossref","first-page":"S1732","DOI":"10.21037\/jtd.2019.03.83","article-title":"Detection, classification, and management of rejection after lung transplantation","volume":"11","author":"Parulekar","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.ajt.2024.10.006_bib41","first-page":"A3946","article-title":"B and plasma cell populations drive chronic rejection after lung transplantation","volume":"205","author":"Bueno","year":"2022","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524006348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613524006348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:58:02Z","timestamp":1769907482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613524006348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1600613524006348"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2024.10.006","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum and tissue biomarkers of plasma cell-rich rejection in liver transplant recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}